IMVT-1401-3202
IMVT-1401-3202: A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants with Active Thyroid Eye Disease
3 available clinical trials fall under the “Ophthalmology” category.